Clinical Trial Update: Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients [NA]

View source ↗

Summary

The study evaluating doxorubicin-associated cardiac remodeling with cardiac MRI in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Doxorubicin-induced Cardiomyopathy

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Breast Cancer Female, Doxorubicin Induced Cardiomyopathy | NA | Status: COMPLETED